SCHEDULE 13G

QUINCE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 22053A107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Sofinnova Capital VIII

  Shares: 2,397,711.00 · Class: 5.4%

• Sofinnova Partners SAS, a French corporation

  Shares: 2,397,711.00 · Class: 5.4%

• Antoine Papiernik

  Shares: 2,397,711.00 · Class: 5.4%

• Henrijette Richter

  Shares: 2,397,711.00 · Class: 5.4%

• Maina Bhaman

  Shares: 2,397,711.00 · Class: 5.4%

• Graziano Seghezzi

  Shares: 2,397,711.00 · Class: 5.4%

• Anta Gkelou

  Shares: 2,397,711.00 · Class: 5.4%

• Karl Naegler

  Shares: 2,397,711.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.